相关实验视频

Updated: Jan 17, 2026

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.7K

用深度学习预测阿尔茨海默氏症认知状态的纵向方法.

Houjun Liu1, Alyssa Mae Weakley2, Hiroko H Dodge3

  • 1Computer Science, Stanford University, Stanford, California, USA.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|September 25, 2025
PubMed
概括

这项研究引入了一种新的深度学习方法,用于预测认知能力在3-10年内下降. 这种新技术在预测无记忆性轻度认知障碍 (aMCI) 和阿尔茨海默病 (AD) 进展方面显示出更高的准确性.

关键词:
阿尔茨海默氏症疾病研究中心阿尔茨海默氏症痴呆症是一种痴呆症.国家阿尔茨海默氏症协调中心数据科学数据科学深度学习是一种深度学习.机器学习是机器学习.轻度的认知障碍 轻度的认知障碍变压器 变压器

更多相关视频

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment08:43

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment

Published on: August 7, 2017

8.4K
Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage06:46

Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage

Published on: August 4, 2018

12.7K

相关概念视频

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
824